Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Rises By 38.5%

BriaCell Therapeutics Corp. (NASDAQ:BCTXWGet Free Report) was the recipient of a large increase in short interest in May. As of May 31st, there was short interest totalling 3,600 shares, an increase of 38.5% from the May 15th total of 2,600 shares. Based on an average daily volume of 62,800 shares, the short-interest ratio is presently 0.1 days.

BriaCell Therapeutics Trading Up 0.9%

NASDAQ BCTXW opened at $0.07 on Thursday. BriaCell Therapeutics has a twelve month low of $0.02 and a twelve month high of $0.70. The firm’s 50 day moving average price is $0.09 and its two-hundred day moving average price is $0.15.

About BriaCell Therapeutics

(Get Free Report)

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.

Read More

Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.